Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1175 of 1475 entries
View as:

Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02034591 Org: User:
Start: 10/31/11 End: 11/30/11 Due: 11/30/12

A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time

Phase: N/A Priority: Normal
NCT ID: NCT04263350 Org: User:
Start: 02/26/20 End: 11/17/20 Due: 11/17/21

Drug Interaction Study With Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02101125 Org: User:
Start: 03/31/14 End: 05/31/14 Due: 05/31/15

Methotrexate - Inadequate Response Device Sub-Study

Phase: N/A Priority: Normal
NCT ID: NCT01173120 Org: User:
Start: 11/30/09 End: 07/31/10 Due: 07/31/11

Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163

Phase: N/A Priority: Normal
NCT ID: NCT01454115 Org: User:
Start: 06/30/07 End: 03/31/09 Due: 03/31/10

A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT05421299 Org: User:
Start: 09/16/19 End: 02/15/21 Due: 02/15/22

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01718158 Org: User:
Start: 01/31/13 End: 10/31/14 Due: 10/31/15

Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells

Phase: N/A Priority: Normal
NCT ID: NCT03644498 Org: User:
Start: 05/02/18 End: 10/17/18 Due: 10/17/19

Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)

Phase: N/A Priority: Normal
NCT ID: NCT02038946 Org: User:
Start: 03/26/14 End: 12/28/20 Due: 12/28/21

Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01232127 Org: User:
Start: 02/28/11 End: 06/30/11 Due: 06/30/12

A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002360 Org: User:
Start: 03/31/99 End: 03/31/99 Due: 03/31/00

A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT03143153 Org: User:
Start: 06/29/17 End: 01/13/25 Due: 01/13/26

Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT06425198 Org: User:
Start: 06/10/24 End: 12/30/24 Due: 12/30/25

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00135382 Org: User:
Start: 06/30/02 End: 10/31/05 Due: 10/31/06

Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia

Phase: N/A Priority: Normal
NCT ID: NCT02839629 Org: User:
Start: 11/23/15 End: 05/07/21 Due: 05/07/22

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00803374 Org: User:
Start: 11/30/10 End: 01/31/13 Due: 01/31/14

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00508287 Org: User:
Start: 08/31/07 End: 11/30/07 Due: 11/30/08

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Phase: N/A Priority: Normal
NCT ID: NCT01820572 Org: User:
Start: 03/27/13 End: 10/24/19 Due: 10/24/20

Safety Study to Evaluate BMS-830216 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00878020 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03142165 Org: User:
Start: 05/11/17 End: 11/29/17 Due: 11/29/18

Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00084253 Org: User:
Start: 06/30/04 End: - Due: -

Study of MDX-010 in Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00083278 Org: User:
Start: 05/31/03 End: 02/28/06 Due: 02/28/07

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

Phase: N/A Priority: Normal
NCT ID: NCT00357604 Org: User:
Start: 07/31/06 End: 11/30/06 Due: 11/30/07

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

Phase: N/A Priority: Normal
NCT ID: NCT02095860 Org: User:
Start: 04/30/14 End: 05/31/14 Due: 05/31/15

A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02574078 Org: User:
Start: 11/23/15 End: 04/15/20 Due: 04/15/21